Condition
Renal Failure, End Stage
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
3 treatments under study, led by Atdcnantes
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
3Total
Phase 1/2 (2)
Phase 4 (1)
Trial Status
Unknown1
Terminated1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Research Network
Common Treatments
- Atdcnantes1
- Donor M Reg Mregukr1
- Simvastatin1
Active Sponsors
- Nantes University Hospital1
- Federal University of São Paulo1
- University of Regensburg1
Top Investigators
University Hospital Regensburg, University of Regensburg
University Hospital Regensburg, University of Regensburg
University Hospital Regensburg
Federal University of São Paulo
University Hospital Regensburg, University of Regensburg
Related Conditions
- Peritoneal Dialysis1